NCT05370521 2025-10-09A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal AndrogensSpruce BiosciencesPhase 2 Terminated27 enrolled 18 charts
NCT04373265 2024-02-23Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)Corcept TherapeuticsPhase 1 Completed15 enrolled